1 Study Coverage 1.1 Prostate Cancer Therapeutics Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Introduction 1.2 Global Prostate Cancer Therapeutics Outlook 2017 VS 2022 VS 2028 1.2.1 Global Prostate Cancer Therapeutics Market Size for the Year 2017-2028 1.2.2 Global Prostate Cancer Therapeutics Market Size for the Year 2017-2028 1.3 Prostate Cancer Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Prostate Cancer Therapeutics in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Prostate Cancer Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Prostate Cancer Therapeutics Market Dynamics 1.4.1 Prostate Cancer Therapeutics Industry Trends 1.4.2 Prostate Cancer Therapeutics Market Drivers 1.4.3 Prostate Cancer Therapeutics Market Challenges 1.4.4 Prostate Cancer Therapeutics Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Prostate Cancer Therapeutics by Type 2.1 Prostate Cancer Therapeutics Market Segment by Type 2.1.1 Drugs 2.1.2 Medical Devices 2.2 Global Prostate Cancer Therapeutics Market Size by Type (2017, 2022 & 2028) 2.3 Global Prostate Cancer Therapeutics Market Size by Type (2017-2028) 2.4 United States Prostate Cancer Therapeutics Market Size by Type (2017, 2022 & 2028) 2.5 United States Prostate Cancer Therapeutics Market Size by Type (2017-2028) 3 Prostate Cancer Therapeutics by Sale Channel 3.1 Prostate Cancer Therapeutics Market Segment by Sale Channel 3.1.1 Hospital Pharmacy 3.1.2 Retail Pharmacy 3.1.3 Online Sales 3.2 Global Prostate Cancer Therapeutics Market Size by Sale Channel (2017, 2022 & 2028) 3.3 Global Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2028) 3.4 United States Prostate Cancer Therapeutics Market Size by Sale Channel (2017, 2022 & 2028) 3.5 United States Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2028) 4 Global Prostate Cancer Therapeutics Competitor Landscape by Company 4.1 Global Prostate Cancer Therapeutics Market Size by Company 4.1.1 Top Global Prostate Cancer Therapeutics Companies Ranked by Revenue (2021) 4.1.2 Global Prostate Cancer Therapeutics Revenue by Player (2017-2022) 4.2 Global Prostate Cancer Therapeutics Concentration Ratio (CR) 4.2.1 Prostate Cancer Therapeutics Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Prostate Cancer Therapeutics in 2021 4.2.3 Global Prostate Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Prostate Cancer Therapeutics Headquarters, Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.1 Global Prostate Cancer Therapeutics Headquarters and Area Served 4.3.2 Global Prostate Cancer Therapeutics Companies Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Prostate Cancer Therapeutics Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Prostate Cancer Therapeutics Market Size by Company 4.5.1 Top Prostate Cancer Therapeutics Players in United States, Ranked by Revenue (2021) 4.5.2 United States Prostate Cancer Therapeutics Revenue by Players (2020, 2021 & 2022) 5 Global Prostate Cancer Therapeutics Market Size by Region 5.1 Global Prostate Cancer Therapeutics Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Prostate Cancer Therapeutics Market Size by Region (2017-2028) 5.2.1 Global Prostate Cancer Therapeutics Market Size by Region: 2017-2022 5.2.2 Global Prostate Cancer Therapeutics Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Prostate Cancer Therapeutics Market Size YoY Growth 2017-2028 6.1.2 North America Prostate Cancer Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Prostate Cancer Therapeutics Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Prostate Cancer Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Prostate Cancer Therapeutics Market Size YoY Growth 2017-2028 6.3.2 Europe Prostate Cancer Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Prostate Cancer Therapeutics Market Size YoY Growth 2017-2028 6.4.2 Latin America Prostate Cancer Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Prostate Cancer Therapeutics Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Prostate Cancer Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Sanofi 7.1.1 Sanofi Company Details 7.1.2 Sanofi Business Overview 7.1.3 Sanofi Prostate Cancer Therapeutics Introduction 7.1.4 Sanofi Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.1.5 Sanofi Recent Development 7.2 Pfizer 7.2.1 Pfizer Company Details 7.2.2 Pfizer Business Overview 7.2.3 Pfizer Prostate Cancer Therapeutics Introduction 7.2.4 Pfizer Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.2.5 Pfizer Recent Development 7.3 Amgen 7.3.1 Amgen Company Details 7.3.2 Amgen Business Overview 7.3.3 Amgen Prostate Cancer Therapeutics Introduction 7.3.4 Amgen Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.3.5 Amgen Recent Development 7.4 Johnson & Johnson 7.4.1 Johnson & Johnson Company Details 7.4.2 Johnson & Johnson Business Overview 7.4.3 Johnson & Johnson Prostate Cancer Therapeutics Introduction 7.4.4 Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.4.5 Johnson & Johnson Recent Development 7.5 AstraZeneca 7.5.1 AstraZeneca Company Details 7.5.2 AstraZeneca Business Overview 7.5.3 AstraZeneca Prostate Cancer Therapeutics Introduction 7.5.4 AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.5.5 AstraZeneca Recent Development 7.6 AbbVie 7.6.1 AbbVie Company Details 7.6.2 AbbVie Business Overview 7.6.3 AbbVie Prostate Cancer Therapeutics Introduction 7.6.4 AbbVie Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.6.5 AbbVie Recent Development 7.7 Bayer 7.7.1 Bayer Company Details 7.7.2 Bayer Business Overview 7.7.3 Bayer Prostate Cancer Therapeutics Introduction 7.7.4 Bayer Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.7.5 Bayer Recent Development 7.8 Ipsen Group 7.8.1 Ipsen Group Company Details 7.8.2 Ipsen Group Business Overview 7.8.3 Ipsen Group Prostate Cancer Therapeutics Introduction 7.8.4 Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.8.5 Ipsen Group Recent Development 7.9 Endo Pharmaceuticals 7.9.1 Endo Pharmaceuticals Company Details 7.9.2 Endo Pharmaceuticals Business Overview 7.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Introduction 7.9.4 Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.9.5 Endo Pharmaceuticals Recent Development 7.10 Dendreon Corporation(Sanpower Group Co. Ltd.) 7.10.1 Dendreon Corporation(Sanpower Group Co. Ltd.) Company Details 7.10.2 Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview 7.10.3 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Introduction 7.10.4 Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2017-2022) 7.10.5 Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Prostate Cancer Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Prostate Cancer Therapeutics Market Trends Table 3. Prostate Cancer Therapeutics Market Drivers Table 4. Prostate Cancer Therapeutics Market Challenges Table 5. Prostate Cancer Therapeutics Market Restraints Table 6. Global Prostate Cancer Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Prostate Cancer Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Prostate Cancer Therapeutics Market Size by Sale Channel: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Prostate Cancer Therapeutics Market Size by Sale Channel: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Prostate Cancer Therapeutics Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Prostate Cancer Therapeutics Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Prostate Cancer Therapeutics Revenue Share by Player, 2017-2022 Table 13. Global Prostate Cancer Therapeutics Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Prostate Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics as of 2021) Table 15. Top Players of Prostate Cancer Therapeutics in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Prostate Cancer Therapeutics Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Prostate Cancer Therapeutics Players in United States Market, Ranking by Revenue (2021) Table 20. United States Prostate Cancer Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Prostate Cancer Therapeutics Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Prostate Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Prostate Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Prostate Cancer Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Prostate Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Prostate Cancer Therapeutics Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Prostate Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Prostate Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Prostate Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Sanofi Company Details Table 31. Sanofi Business Overview Table 32. Sanofi Prostate Cancer Therapeutics Product Table 33. Sanofi Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 34. Sanofi Recent Development Table 35. Pfizer Company Details Table 36. Pfizer Business Overview Table 37. Pfizer Prostate Cancer Therapeutics Product Table 38. Pfizer Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 39. Pfizer Recent Development Table 40. Amgen Company Details Table 41. Amgen Business Overview Table 42. Amgen Prostate Cancer Therapeutics Product Table 43. Amgen Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 44. Amgen Recent Development Table 45. Johnson & Johnson Company Details Table 46. Johnson & Johnson Business Overview Table 47. Johnson & Johnson Prostate Cancer Therapeutics Product Table 48. Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 49. Johnson & Johnson Recent Development Table 50. AstraZeneca Company Details Table 51. AstraZeneca Business Overview Table 52. AstraZeneca Prostate Cancer Therapeutics Product Table 53. AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 54. AstraZeneca Recent Development Table 55. AbbVie Company Details Table 56. AbbVie Business Overview Table 57. AbbVie Prostate Cancer Therapeutics Product Table 58. AbbVie Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 59. AbbVie Recent Development Table 60. Bayer Company Details Table 61. Bayer Business Overview Table 62. Bayer Prostate Cancer Therapeutics Product Table 63. Bayer Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 64. Bayer Recent Development Table 65. Ipsen Group Company Details Table 66. Ipsen Group Business Overview Table 67. Ipsen Group Prostate Cancer Therapeutics Product Table 68. Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 69. Ipsen Group Recent Development Table 70. Endo Pharmaceuticals Company Details Table 71. Endo Pharmaceuticals Business Overview Table 72. Endo Pharmaceuticals Prostate Cancer Therapeutics Product Table 73. Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 74. Endo Pharmaceuticals Recent Development Table 75. Dendreon Corporation(Sanpower Group Co. Ltd.) Company Details Table 76. Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview Table 77. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product Table 78. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 79. Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Prostate Cancer Therapeutics Product Picture Figure 2. Global Prostate Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Prostate Cancer Therapeutics Market Size 2017-2028 (US$ Million) Figure 4. United States Prostate Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Prostate Cancer Therapeutics Market Size 2017-2028 (US$ Million) Figure 6. United States Prostate Cancer Therapeutics Market Share in Global 2017-2028 Figure 7. Prostate Cancer Therapeutics Report Years Considered Figure 8. Product Picture of Drugs Figure 9. Product Picture of Medical Devices Figure 10. Global Prostate Cancer Therapeutics Market Share by Type in 2022 & 2028 Figure 11. Global Prostate Cancer Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Prostate Cancer Therapeutics Market Share by Type (2017-2028) Figure 13. United States Prostate Cancer Therapeutics Market Share by Type in 2022 & 2028 Figure 14. United States Prostate Cancer Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Prostate Cancer Therapeutics Market Share by Type (2017-2028) Figure 16. Product Picture of Hospital Pharmacy Figure 17. Product Picture of Retail Pharmacy Figure 18. Product Picture of Online Sales Figure 19. Global Prostate Cancer Therapeutics Market Share by Sale Channel in 2022 & 2028 Figure 20. Global Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2028) & (US$ Million) Figure 21. Global Prostate Cancer Therapeutics Market Share by Sale Channel (2017-2028) Figure 22. United States Prostate Cancer Therapeutics Market Share by Sale Channel in 2022 & 2028 Figure 23. United States Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2028) & (US$ Million) Figure 24. United States Prostate Cancer Therapeutics Market Share by Sale Channel (2017-2028) Figure 25. North America Prostate Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Prostate Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Prostate Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Prostate Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Prostate Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Prostate Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Sanofi Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 54. Pfizer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 55. Amgen Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 56. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 57. AstraZeneca Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 58. AbbVie Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 59. Bayer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 60. Ipsen Group Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 61. Endo Pharmaceuticals Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 62. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Sanofi Pfizer Amgen Johnson & Johnson AstraZeneca AbbVie Bayer Ipsen Group Endo Pharmaceuticals Dendreon Corporation(Sanpower Group Co. Ltd.)